Summary
Navin Fluorine International Limited - Q3 FY26 Earnings Call Summary Monday, February 09, 2026, 4:00 PM IST
Event Participants
Executives 3 Anish Ganatra (CFO), Nitin Kulkarni (MD), Vishad Mafatlal (Chairman)
Analysts 8 Abhijit (Kotak Securities), Archit Joshi (Nuvama), Arun (Avendus Spark), Jason (IDBI Capital), Nirav (Anvil Wealth), Nitesh (Anand Rathi), Sajan Kapoor (Antifragile Thinking), Sanjesh Jain (ICICI Securities), Surya (PhillipCapital), Vivek (Morgan Stanley)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue (Consolidated) | ₹892 crores | +47% YoY, +18% QoQ. Driven by record specialty chemicals performance and strong CDMO traction. |
| EBITDA (Operating) | ₹308 crores | +109% YoY, +25% QoQ. Expansion driven by operating leverage and manufacturing efficiencies. |
| EBITDA Margin | 34.5% | +1,020 bps YoY, +200 bps QoQ. Reflects improved realization in HPP and high-margin CDMO mix. |
| PAT (Consolidated) | ₹185 crores | +122% YoY, +25% QoQ. Net debt-to-equity remains low at 0.03x. |
| Specialty Chemicals Revenue | ₹354 crores | +60% YoY. Highest-ever quarterly revenue; driven by scale-up in Nectar project and new launches. |
| HPP Revenue | ₹412 crores | +35% YoY. Supported by constructive pricing environment and higher R-32 volumes. |
| CDMO Revenue | ₹127 crores | +61% YoY. Driven by successful validation and commercial supplies from cGMP-4 facility. |
| Net Working Capital | < 80 days | Sequential improvement demonstrating disciplined growth management. |
Geographic & Segment Commentary
- Specialty Chemicals: Achieved record quarterly revenue driven by the Nectar project reaching 50% utilization and the launch of one to two new molecules per quarter. The segment is shifting from a transactional model to a strategic technology partnership with global agchem majors.
- HPP (High Performance Products): Performance remains robust with R-32 capacity at 100% utilization. Recent commissioning of the AHF (Anhydrous Hydrogen Fluoride) “mother plant” provides a foundation for high-value downstream fluorinated chemistries.
- CDMO (Contract Development and Manufacturing): Strong momentum following the commissioning of the cGMP-4 Phase-1 facility for a European major. The segment maintains a balanced 50-50 split between early-stage and late-stage/commercial molecules, positioning it to hit the $100 million revenue aspiration.
Company-Specific & Strategic Commentary
- Wave-1 & Wave-2 Projects: Successfully concluded Wave-1 (AHF and cGMP-4). Wave-2 projects (Chemours, MPP debottlenecking, and R-32 expansion) remain on track for FY27 completions.
- Advanced Materials & Semiconductors: Evaluating entry into the electronic chemical value chain (including BF-3 and high-purity gases) to capitalize on India’s Semiconductor Mission 2.0.
- Vertical Integration: The new AHF capacity is strategic, intended to reduce external dependence while fueling niche, high-realization downstream applications rather than commodity trade.
- Manufacturing Excellence: Focus on the “lift, shift, adapt, embed” model to drive process improvements and yield optimization, which contributed to the current quarter’s 34.5% EBITDA margin.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Annual EBITDA Margin | ~30% (+/- 200 bps) | Management expects long-term stabilization at this level; current high margins are partly campaign-driven. |
| Wave-2 Commissioning | Q1 - Q3 FY27 | MPP debottlenecking and R-32 expansion (15k MTPA) targeted for Q3 FY27; Chemours for Q1 FY27. |
| CDMO Revenue Target | $100 million | Aspirational mid-term target supported by late-stage molecule readouts and cGMP-4 ramp-up. |
| Nectar Project Utilization | ~100% (FY27) | Expected to double from current 50% levels as more volumes are secured with partners. |
Risks & Constraints
| Risk | Context |
|---|---|
| Raw Material Volatility | Rising costs of Sulfur and Fluorspar remain key headwinds. Management is mitigating this through pricing adjustments and captive AHF production. |
| Agchem Cyclicality | While the outlook for FY27 is improving, pricing pressure in the global agrochemical market remains a structural reality. |
| Commercial Sensitivities | New projects in the semiconductor and Advanced Materials space are currently in evaluation stages with high confidentiality, limiting immediate visibility. |
Q&A Highlights
Segmental Growth & Utilization
- Question: What is driving the sharp sequential growth in the subsidiary (NFASL)? (Sanjesh Jain)
- Answer: Growth is primarily from the Nectar ramp-up and the specialty pipeline. MPP-1 is at par, MPP-2 is at 70-80%, and Nectar is at 50% utilization (Anish Ganatra).
Margin Sustainability
- Question: How sustainable are the 34.5% margins? (Arun)
- Answer: Current margins reflect a beneficial product mix and operating leverage. On an annualized basis, investors should model 30% (+/- 200 bps) as different campaigns have varied margin profiles (Anish Ganatra).
Semiconductor Opportunity
- Question: Why is the company downplaying solar in favor of semiconductor grade? (Sanjesh Jain)
- Answer: The company is building capacity to access electronic-grade markets. Solar is not excluded, but the focus is on higher-purity, niche-value gases like BF-3 (Anish Ganatra).
Refrigerant Mix
- Question: Has the R-32 mix changed, and are export realizations better? (Nitesh/Abhijit)
- Answer: Export realizations for R-32 are currently superior to domestic. New capacity (15,000 MTPA) is being prepared for global market placement (Anish Ganatra).
Key Takeaway
Navin Fluorine delivered a record-breaking performance in Q3 FY26, with revenue growing 47% YoY to ₹892 crores and EBITDA margins expanding significantly to 34.5%. The quarter was marked by the successful completion of “Wave-1” CAPEX projects, including the AHF mother plant and cGMP-4 facility, which have already begun contributing to commercial supplies. The Specialty Chemicals vertical achieved its highest-ever quarterly revenue, signaling a successful shift toward strategic technology partnerships with global innovators. Management remains focused on “Wave-2” expansions, including the Chemours liquid cooling project and R-32 capacity additions, both slated for FY27. While raw material inflation in Fluorspar and Sulfur remains a watch point, the company is well-positioned to leverage the Indian Semiconductor Mission 2.0 and global AI-driven data center growth. Navin Fluorine continues to transition into a high-value fluorinated solutions provider with a sustainable long-term annual margin profile of approximately 30%.
Want more insights like this?
Subscribe to get deep dives delivered to your inbox.
More Earnings Summaries
Explore more Q3 FY26 earnings call analyses: